{"id":"W7117315492","doi":"10.1016/j.iotech.2025.101210","title":"126P Neoadjuvant (neoadj) nivolumab (N) + chemotherapy (C) in patients (pts) with resectable NSCLC: Outcomes by subsequent immunotherapy (IO) in CheckMate 816","year":2025,"lang":"en","type":"article","venue":"Immuno-Oncology Technology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"Trinity College; McGill University Health Centre","funders":"","keywords":"Nivolumab; Chemotherapy; Immunotherapy; Chemoimmunotherapy; Neoadjuvant therapy; MEDLINE","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001642367,0.0001768874,0.000326293,0.0000999631,0.0001431042,0.0004411949,0.0001298559,0.0002449023,0.001565885],"category_scores_gemma":[0.0004005452,0.00008630339,0.0005184008,0.0001436967,0.0001544726,0.0003046592,0.0002217601,0.0004972481,0.0002507028],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000390971,"about_ca_system_score_gemma":0.0003686917,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001326157,"about_ca_topic_score_gemma":0.003028084,"domain_scores_codex":[0.999928,0.00001416755,0.000004062701,0.00002102946,0.000007824179,0.00002492033],"domain_scores_gemma":[0.9998423,0.00002911838,0.00003560939,0.00001118363,0.000008457091,0.00007329693],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.2157743,0.002860086,0.6228862,0.0003173039,0.0007676609,0.0006248847,0.0001718219,0.00198179,0.01281125,0.0002702514,0.003685111,0.1378492],"study_design_scores_gemma":[0.005099119,0.05147898,0.9309587,0.00009771744,0.001046114,0.0006974609,0.0002370546,0.002439148,0.002729906,0.0003317851,0.004853801,0.00003034244],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9980748,0.0007167555,0.00005212038,0.00007577875,0.00003257526,0.00001411704,0.0001946788,0.000006918575,0.0008323085],"genre_scores_gemma":[0.9985525,0.0002209066,0.00005179384,0.00008970773,0.00002489565,0.00001313669,0.0004943619,0.000001590117,0.0005511467],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001565885,"threshold_uncertainty_score":0.005238354,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.005142110023032019,"score_gpt":0.2744393243525463,"score_spread":0.2692972143295143,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}